Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

Go to Regulatory Recap News

Subscribe for Weekly Updates

The Advocacy &  Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.

Subscribe

Spotlight

Georgia Introduces Prescription Drug Reform Bill

The bill would allow payers to direct prescriptions to pharmacy networks and create limits for physician dispensing and compounds.

Read More →

February 9, 2026

Spotlight

Access to Care Claims Procedures

Arizona Bill Could Expand Worker Choice in Medical Care

Senate Bill 1404 could grant workers greater choice over their provider, pharmacy, certain ancillary services, and more.

Read More →

February 9, 2026

Spotlight

Cost Containment Treatment Guidelines

Hawaii Bills Target Pharmacy Management Rules

New bills would address compounds, deadlines for authorization decisions, and more.

Read More →

February 2, 2026

Access to Care Claims Procedures

Arizona Pharmacy Network Bill Fails to Pass

The bill did not pass out of its original committee before a crucial deadline, and failed to pass after a special hearing.

Read More →

February 23, 2026

Cost Containment Treatment Guidelines

Hawaii Amends Bill to Target Physician Dispensing

Originally meant to address compound medications, the bill has been expanded to create limitations for physician dispensing.

Read More →

February 23, 2026

Ancillary Services Billing & Payments Cost Containment

Alaska Updates Medical Fee Schedule

In a February 19th special meeting, the Board approved new rules and addressed confusion regarding resource materials

Read More →

February 23, 2026

Claim Data

California Reports That COVID-19 Drove Recent Increases in Injury and Illness

Using data from the Bureau of Labor Statistics, the CWCI found that COVID-19 drove recent increases in injury and illness, with rates decreasing lately.

Read More →

February 23, 2026

Access to Care Ancillary Services

Oregon Extends Sign Language Interpreter Licensing Pause

Prolonged licensure pauses risk reducing interpreter availability and disrupting access to care.

Read More →

February 23, 2026

Advocacy Opportunity Treatment Guidelines

Tennessee Medical Advisory Committee Meeting Recap

The meeting covered potential updates to treatment guidelines, specifically for physical therapy, as well as other topics.

Read More →

February 16, 2026

1 2 3 … 45 Next »

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.

hello world!

Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Expert Q&A: What Utah’s AI Prescription Renewal Pilot Signals About the Evolving Role of AI in Treatment Decisions

Utah’s prescription renewal pilot is a groundbreaking use case for AI in healthcare. What are the potential benefits and pitfalls?

The Cost of Exposure: How Occupational Cancer Impacts Workers’ Compensation

The risk and impact of occupational cancers vary significantly depending on the nature of the exposure and the affected workforce.

Utah Launches AI Prescription Renewal Pilot Program for Chronic Conditions

The pilot can approve a limited set of 192 medications and will be broken into three stages, each with different levels of review.

States Seek to Limit AI-Generated Care Decisions, Despite White House Order

Legislators continue to introduce bills to limit AI-generated healthcare decisions, even as the U.S. Attorney General has been instructed to oppose them.